Apple’s blood-oxygen reading function is in legal danger … again

Apple has just reintroduced a blood oxygen reading function to certain Apple watches last week, but a new trial could force the business to turn it off again.

On Wednesday, the health technology company continued customs and the protection of American border on an agency decision that enabled Apple to restore functionality. Masimo had already pursued Apple, saying that society had violated its patents.

The trial calendar occurs while Apple has pushed more deep into medical devices, while behaving towards the Trump administration in what some speculated is an effort to guarantee favorable pricing policies.

The trial

Masimo says that the CBP illegally allowed Apple to reactivate the monitoring of blood-oxygen on its watches, even if the functionality tears Masimo technology.

In a legal action filed Wednesday before the Federal Court, the manufacturer of medical aircraft argued that the CBP exceeded its authority with a decision of August 1 which canceled its own decision in January.

“It has now been revealed that the CBP then overturned without any significant justification, without any significant change in the circumstances, and without any notice to Masimo, not to mention the occasion for Masimo to be heard,” said the complaint.

Masimo says he only learned about the overthrow when Apple announced on August 14 that he brought the functionality, “activated by a recent American customs decision”. This time, however, the Blood Oxygen application will unload the data from the sensor on the paired iPhone for processing instead of cracking the figures on the watch itself.

Masimo is now looking for a temporary ban prescription and a preliminary injunction to block the CBP decision and restore the initial decision, which had forced Apple to fully deactivate the functionality before selling its watches in the United States

The prohibition of watch functionality has been in place since October 2023, when the US international trade committee found that Apple was focused on two Masimo patents. Apple continued to sell watches with intact equipment, but deactivated the functionality with a software update. His call for the ban on ITC is still pending.

The trial also stresses the time of major Apple interior investment commitments. After announcing more than $ 500 billion in American investments earlier this year, Apple unveiled an additional $ 100 billion at the oval office meeting on August 6 with President Donald Trump.

Apple’s push in health

The new trial also occurs while Apple has increasingly deployed health characteristics on its devices.

Last year, Apple added a scientifically validated hearing aid and a clinical quality hearing aid to its AirPods Pro 2, allowing them to make “personalized dynamic adjustments” to amplify sounds in real time. The company has also deployed a new sleep apnea functionality for its watches – an algorithm which can detect signs of moderate to severe sleep apnea by analyzing respiratory disturbances.